Effect of eluent pH on the HPLC-UV analysis of hyperforin from St. John's Wort (Hypericum perforatum L.)

Phytochemical Analysis

Volumn 17, Issue 2, 2006, Pages 71-77

  Fourneron, Jean Dominique ^a   Naït Si, Youssef ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

HPLC PAD analysis; Hyperforin; St. John's Wort; UV spectroscopy

Indexed keywords

ALKALINITY; CHROMATOGRAPHIC ANALYSIS; PH EFFECTS; SPECTRUM ANALYSIS;

ALKALINES; ELUENTS; HPLC ANALYSIS; HPLC-PAD ANALYSE; HPLC-UV ANALYSIS; HYPERFORINS; HYPERICUM PERFORATUM L; MOBILE PHASIS; ST JOHN'S WORT; UV SPECTRUM;

ULTRAVIOLET SPECTROSCOPY;

HYPERFORIN; HYPERICIN; HYPERICUM PERFORATUM EXTRACT;

ACIDITY; ALKALINITY; ARTICLE; CONTROLLED STUDY; DRUG ISOLATION; DRUG PURIFICATION; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; SOLVENT EXTRACTION; ULTRAVIOLET SPECTROSCOPY;

HYPERICUM PERFORATUM;

EID: 33645568719     PISSN: 09580344     EISSN: 10991565     Source Type: Journal    
DOI: 10.1002/pca.888     Document Type: Article

References (22)

1. Adam P, Arigoni D, Bacher A, Eisenreich W. 2002. Biosynthesis of hyperforin in Hypericum perforatum. J Med Chem 45: 4786-4793.
2. Brondz I, Greibrokk T, Groth PA, Aasen AJ. 1982. The relative stereochemistry of hyperforin - an antibiotic from Hypericum perforatum. Tetrahedron Lett 23: 1299-1300.
3. Brondz I, Greibrokk T, Groth PA, Aasen AJ. 1983. The absolute configuration of hypertorin from Hypericum perforatum L., Based on the crystal structure of its p-bromobenzoate ester. Acta Chem Scand, Ser A 37: 263-265.
4. Butterweck V, Nahrstedt A. 2003. What is known about St. John's Wort? Phytochemistry and pharmacology. Pharmazie Unser Zeit 32: 212-219.
5. Butterweck V, Christoffel V, Nahrstedt A, Petereit F, Spengler B, Winterhoff H. 2003. Step by step removal of hyperforin and hypericin: Activity profile of different Hypericum preparations in behavioural models. Life Sci 73: 627-639.
6. Chatterjee SS, Nolder M, Koch E, Erdelmeier C. 1998. Antidepressent activity of Hypericum perforatum and hyperforin: The neglected possibility. Pharmacopsychiatry 31: 7-15.
7. Chatterjee SS, Erdelmeier C, Klessing K, Marme D, Schaechtele C. 1999. Stable hyperforin salts, method for their production, and their use in treatment of Alzheimer's disease. PCT International Application WO 9941220.
8. De los Reyes GC, Koda RT. 2001. Development of a simple, rapid and reproducible HPLC assay for the simultaneous determination of hypericins and stabilized hyperforin in commercial St. John's Wort preparation. J Pharm Biomed Anal 26: 959-965.
9. Erdelmeier C. 1998. Hyperforin, possibly the major non-nitrogenous secondary metabolite of Hypericum perforatum L. Pharmaco-psychiatry 31: 2-6.
10. Fourneron J-D, Herbette G, Caloprisco E. 1999. Pseudohypericin and hypericin in St. John's Wort extracts. Breakdown of pseudohypericin. CR Acad Sci Ser I 127-131.
11. Fourneron J-D, Naït-Si Y, Rosas R, Faure R, Viant P. 2003. Identification of isopseudohypericin, a new phenanthroperylen quinone obtained from the alkaline treatment of pseudohypericin Tetrahedron Lett 44: 6285-6288.
12. Fuzzati N, Gabetta B, Strepponi I, Villa F. 2001. High-performance liquid chromatography-electrospray ionization mass spectrometry and multiple mass spectrometry studies of hyperforin degradation products. J Chromatogr A 926: 187-198.
13. Ganzera M, Zhao J, Khan IA. 2002. Hypericum perforatum-chemical profiling and quantitative results of St. John's Wort products by improved high-performance liquid chromatography method. J Pharm Sci 91: 623-630.
14. Gray D, Rottinghaus GE, Garrett HEG, Pallardy SG. 2000. Simultaneous determination of the predominant hyperforins and hypericins in St. John's Wort (Hypericum perforatum L.) by liquid chromatography. J AOAC Int 83: 944-949.
15. Gurevich AI, Dobrynin VN, Kolosov MN, Popravko SA, Ryabova ID, Chernov BK, Derbentseva NA. 1971. Hyperforin, an antibiotic from Hypericum perforatum. Antibiotiki 16: 510-513.
16. Liu F, Pan C, Drumm P, Ang CYW. 2005. Liquid chromatography-mass spectrometry studies of St. John's Wort methanol extraction: Active constituents and their transformation. J. Pharm. Biomed. Anal. 37: 303-312.
17. Naït-Si Y, 2002. Ph.D. Thesis, University of Aix-Marseille III.
18. Naït-Si Y, Fourneron J-D. 2004. Hypericin and pseudohypericin: Purity criteria and quantitative determination in extracts of St John's Wort (Hypericum perforatum). Monatsh Chem 135: 1319-1326.
19. Naït-Si Y, Fourneron J-D. 2005. Chemical and chromatographic behaviour of pseudohypericin and isopseudohypericin, and the occurrence of isopseudohypericin in St. John's Wort (Hypericum perforatum) extracts. Monatsh Chem 136: 159-168.
20. Orth HCJ, Hauer H, Erdelmeier CAJ, Schmidt PC. 1999a. Orthoforin. The main degradation product of hyperforin from Hypericum perforatum. Pharmazie 54: 76-77.
21. Orth HCJ, Rentel C, Schmidt PC. 1999b. Isolation, purity analysis and stability of hyperforin as a standard material from Hypericum perforatum L. J Pharm Pharmac 51: 193-200.
22. Poutaraud A, Lobstein A, Girardin P, Weniger B. 2001. Improved procedure for the quality control of Hypericum perforatum L. Phytochem Anal 12: 355-362.